Actively Recruiting
Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus
Led by Yufan Wang · Updated on 2026-04-23
2920
Participants Needed
3
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to integrate clinical indicators and features of fundus images, combined with metabolomics, to construct an early warning model for diabetic retinopathy (DR) in type 2 diabetes. By combining clinical indicators with metabolomics, the investigators aim to establish a precise DR typing model based on the age of diabetes onset (early-onset diabetes, late-onset diabetes) and based on the coexistence with two types of diabetic macrovascular complications. A multidisciplinary collaboration will be conducted for comprehensive management of DR to control the progression of moderate-stage DR. Cloud-based patient rooms combined with continuous glucose monitoring (CGM) will further explore the role of integrated diabetes retinopathy ward management models in the management of patients undergoing diabetes retinopathy surgery, pioneering a new model for the management of advanced DR.
CONDITIONS
Official Title
Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meet the diagnostic criteria for type 2 diabetes according to the China Type 2 Diabetes Prevention and Treatment Guidelines (2020 Edition)
- Aged between 20 and 79 years old
- Have no other severe underlying diseases
- Have full cognitive and literacy abilities
- Volunteer to participate and are willing to sign an informed consent form
You will not qualify if you...
- Diagnosed with type 1 diabetes or other types of diabetes
- Have severe heart, lung, liver, or kidney failure
- Have mental confusion, speech disorders, or dementia
- Unable to take care of oneself, bedridden, or have mobility impairments
- Are pregnant or breastfeeding
- Have a recent history of surgery, trauma, acute major vascular complications, or infectious diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
The first hosptial of lanzhou university
Lanzhou, China
Actively Recruiting
2
Shanghai general hosptial
Shanghai, China
Actively Recruiting
3
The forth people's hosptial of shenyang
Shenyang, China
Actively Recruiting
Research Team
L
Liping Gu Liping Gu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here